Sofinnova Investments, Inc. Immatics N.V. Transaction History

Sofinnova Investments, Inc.

$1.06 Billion
Q3 2024

A detailed history of Sofinnova Investments, Inc. transactions in Immatics N.V. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 386,100 shares of IMTX stock, worth $2.64 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

386,100

Previous 796,704 51.54%

Holding current value

$2.64 Million

Previous $9.26 Million 52.41%

% of portfolio

0.42%

Previous 0.51%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.93 - $12.92 $4.49 Million - $5.31 Million	-410,604 Reduced 51.54%	386,100 $4.41 Million
Q2 2024 Aug 09, 2024	SELL	$9.78 - $13.49 $13.4 Million - $18.4 Million	-1,366,942 Reduced 63.18%	796,704 $9.26 Million
Q1 2024 Aug 14, 2024	BUY	$10.23 - $12.94 $14 Million - $17.7 Million	1,366,942 Added 171.57%	2,163,646 $22.7 Million
Q1 2024 May 15, 2024	SELL	$10.23 - $12.94 $8.24 Million - $10.4 Million	-805,393 Reduced 27.13%	2,163,646 $22.7 Million
Q4 2023 Aug 15, 2024	BUY	$7.36 - $10.89 $16 Million - $23.7 Million	2,172,335 Added 272.67%	2,969,039 $31.3 Million
Q4 2023 Feb 12, 2024	SELL	$7.36 - $10.89 $533,217 - $788,958	-72,448 Reduced 2.38%	2,969,039 $31.3 Million
Q2 2023 Aug 14, 2023	SELL	$5.92 - $12.72 $539,945 - $1.16 Million	-91,207 Reduced 2.91%	3,041,487 $35.1 Million
Q1 2023 May 11, 2023	BUY	$6.74 - $9.44 $7.63 Million - $10.7 Million	1,131,918 Added 56.57%	3,132,694 $21.6 Million
Q4 2022 Feb 13, 2023	BUY	$8.05 - $11.58 $11.8 Million - $17 Million	1,468,260 Added 275.72%	2,000,776 $17.4 Million
Q3 2022 Nov 08, 2022	SELL	$3.31 - $13.06 $2.52 Million - $9.95 Million	-761,587 Reduced 58.85%	532,516 $5.33 Million
Q2 2022 Aug 15, 2022	BUY	$6.0 - $9.37 $156,240 - $243,994	26,040 Added 2.05%	1,294,103 $11.3 Million
Q1 2022 May 16, 2022	BUY	$6.64 - $12.85 $1.6 Million - $3.1 Million	241,440 Added 23.52%	1,268,063 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$10.81 - $14.38 $5.93 Million - $7.89 Million	548,407 Added 114.68%	1,026,623 $13.8 Million
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $403,516 - $538,719	34,846 Added 7.86%	478,216 $6.22 Million
Q2 2021 Aug 16, 2021	BUY	$10.43 - $12.81 $607,766 - $746,451	58,271 Added 15.13%	443,370 $5.15 Million
Q1 2021 May 14, 2021	BUY	$10.24 - $14.6 $1.08 Million - $1.54 Million	105,567 Added 37.77%	385,099 $4.32 Million
Q4 2020 Feb 16, 2021	SELL	$9.67 - $12.05 $444,771 - $554,239	-45,995 Reduced 14.13%	279,532 $3.02 Million
Q3 2020 Nov 13, 2020	BUY	$8.73 - $15.15 $2.84 Million - $4.93 Million	325,527 New	325,527 $3.45 Million

Others Institutions Holding IMTX

# of Institutions

101

Shares Held

75.8M

Call Options Held

238K

Put Options Held

727K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $522M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account

Sofinnova Investments, Inc. Immatics N.V. Transaction History